SHZ:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:42 UTC

Last close

n/aCNY

Market data

13.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
13.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
18.6%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
14.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Growth is the furthest below its sector's middle: 0.37 against 0.47 on the market's range.

All from 100

lens 2 of 9

Sales

217

2016-12-31 to 2025-12-31100 at the start217

Sales: 100.00 on 2016-12-31 to 216.98 on 2025-12-31, up 117%.

Profit

379

2016-12-31 to 2025-12-31100 at the start379

Profit: 100.00 on 2016-12-31 to 379.46 on 2025-12-31, up 279%.

Shares in issue

108

2016-12-31 to 2025-12-31100 at the start108

Shares in issue: 100.00 on 2016-12-31 to 107.58 on 2025-12-31, up 8%.

Sales is at 217, Profit is at 380, Shares in issue is at 108, against 100 in 2016.

Sales is at 217, Profit is at 380, Shares in issue is at 108, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100217
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100380
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100108
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY